2010—2014 年郑州市第二人民医院眼局部抗青光眼药应用分析.

OBJECTIVE: To investigate the application of local anti-glaucoma drugs in the Second People's Hospital of Zhengzhou (hereinafter referred to as "our hospital"), and then get preliminary information about the clinical application characteristics, drugs distributions and the development tendency of local anti-glaucoma drugs. METHODS: Through drug management system, the consumption amount, consumption sum of anti-glaucoma drugs were statistically collected. And comprehensively analysis was conducted on the defined daily dose (DDD), defined daily dose system (DDDs), and daily drug cost (DDC). RESULTS: The sales amount, consumption sum of local anti-glaucoma drugs were in upward trend in our hospital, while timolol decreased,and travoprost and brimonidine both had a significant increase. DDDs of timolol and travoprost had changed significantly, and the others had no significant change. CONCLUSIONS: Timolol has been gradually replaced by carteolol in the process of clinical application; brinzolamide plays an important role in glaucoma medications; and the use rate of travoprost stepped up steadily yearly in clinical application. [ABSTRACT FROM AUTHOR]